Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study

BACKGROUND: The plasma concentration of patients treated with efavirenz (EFV) 600 mg was found to exceed the upper limit of the proposed therapeutic window in most Chinese HIV-infected individuals; thus, dosage reduction of EFV to 400 mg daily warranted consideration. This study aimed to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ling, Peng, Wenxiu, Song, Xiaojing, Li, Yanling, Han, Yang, Zhu, Ting, Fu, Qiang, Du, Xiaoli, Cao, Wei, Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824943/
https://www.ncbi.nlm.nih.gov/pubmed/33485301
http://dx.doi.org/10.1186/s12879-021-05802-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824943/
https://www.ncbi.nlm.nih.gov/pubmed/33485301
http://dx.doi.org/10.1186/s12879-021-05802-8

Ejemplares similares